Astellas' new $100 million manufacturing facility in Sanford, NC.

Astel­las joins Pfiz­er in emerg­ing North Car­oli­na hub, un­veil­ing new $100M gene ther­a­py man­u­fac­tur­ing site

The small city of San­ford, NC, was once known for its brick pro­duc­tion, but now is quick­ly be­com­ing a hub in the biotech world. And now Astel­las is the lat­est to pitch its tent in the area.

The com­pa­ny’s gene ther­a­py branch, which came out of the ac­qui­si­tion of Au­dentes in 2019, has opened a new man­u­fac­tur­ing fa­cil­i­ty in the city, com­pris­ing 135,000 square feet and shelling out $100 mil­lion. Astel­las de­signed the site to pro­vide clin­i­cal and com­mer­cial-scale man­u­fac­tur­ing ca­pa­bil­i­ties for its pipeline of AAV vec­tors for gene ther­a­pies, which in­cludes pro­grams from both Astel­las and Au­dentes’ port­fo­lios.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.